Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

Cazaubon, Yoann; Talineau, Yohann; Feliu, Catherine; Konecki, Céline; Russello, Jennifer; Mathieu, Olivier; Djerada, Zoubir

Cazaubon, Yoann; Talineau, Yohann; Feliu, Catherine; Konecki, Céline; Russello, Jennifer; Mathieu, Olivier; Djerada, Zoubir.

Afiliação

Cazaubon Y; Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France. ycazaubon@chu-reims.fr.
Talineau Y; Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France. yohann.talineau@gmail.com.
Feliu C; Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France. cfeliu@chu-reims.fr.
Konecki C; Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France. ckonecki@chu-reims.fr.
Russello J; Department of Medical Pharmacology, Montpellier University Hospitals, 34000 Montpellier, France. j-russello@chu-montpellier.fr.
Mathieu O; Department of Medical Pharmacology, Montpellier University Hospitals, 34000 Montpellier, France. o-mathieu@chu-montpellier.fr.
Djerada Z; Department of Medical Pharmacology, EA3801, SFR Cap-Santé, Reims University Hospitals, 51100 Reims, France. zoubir.djerada@univ-reims.fr.

Pharmaceutics ; 11(11)2019 Oct 31.

Article em En | MEDLINE | ID: mdl-31683663